Quantcast

Latest Venous thrombosis Stories

2014-02-26 23:02:53

The Firm is investigating testosterone treatment lawsuits on behalf of men who suffered heart attacks, strokes, deep vein thrombosis, pulmonary embolism, or other serious cardiovascular problems, allegedly due to AndroGel and other low testosterone therapies. New York, NY (PRWEB) February 26, 2014 As testosterone lawsuits (http://www.testosteronelawsuitcenter.com/ ) involving AndroGel continue to mount, Bernstein Liebhard LLP notes that a leading consumer advocacy group is pushing...

2014-02-21 12:24:10

Data show clinically meaningful, ongoing improvements in patients with varicose veins caused by saphenofemoral junction incompetence LONDON, Feb. 21, 2014 /PRNewswire/ -- Today at the 26(th) Annual Meeting of the American Venous Forum in New Orleans, LA, Dr. Kenneth Todd, an American College of Phlebology Committee Member from the Southeast Vein and Laser Center and a Principal Investigator for VANISH-2, presented one-year data from the VANISH-2 clinical trial, one of the two pivotal trials...

2014-02-19 23:30:28

The DrugRisk Center is the largest source on the Web for information on prescription drug research, side effects and legal news. Visit http://www.DrugRisk.com New York, NY (PRWEB) February 19, 2014 The birth control safety advocates at DrugRisk.com are announcing new information to the site for patients who’ve taken the drugs Yaz or Yasmin. Britain’s healthcare agency recently ordered doctors to inform women taking drugs like Yaz and Yasmin that they were twice as likely to develop...

2014-02-19 23:30:15

http://www.DrugNews.net is the web’s premier source for prescription drug warnings, research, side effects and legal news. Visit the DrugNews Center today. New York, NY (PRWEB) February 19, 2014 The birth control safety center at DrugNews.net is alerting users of the contraceptives Yaz or Yasmin of new information on the site. Health experts in the United Kingdom recently ordered a warning for patients that the drugs may greatly increase the rate of blood clots*. At the same time, court...

2014-01-16 23:00:31

The DrugRisk Center is the largest source on the Web for information on prescription drug research, side effects and legal news. Visit http://www.DrugRisk.com Orlando, FL (PRWEB) January 16, 2014 The birth control safety advocates at DrugRisk.com are now offering help to patients who have taken Yaz or Yasmin with questions about settlements. This is in addition to information on the site about the latest research, warnings and legal news on contraceptives like Yaz that use the hormone...

2014-01-08 23:00:18

A NuvaRing lawsuit recently filed by Wright & Schulte alleges that a Florida woman developed deep vein thrombosis and pulmonary embolism due to her use of NuvaRing. Columbus, OH (PRWEB) January 08, 2014 Wright & Schulte is currently representing a woman from Cape Coral, Florida in a recently filed NuvaRing lawsuit (Case No. 2:13-cv-00721-SPC-DNF). This case, which was filed in the U.S. District Court of Ohio, contends that the plaintiff developed serious blood clotting disorders...

2014-01-08 12:30:25

Submission based on the two largest comparative phase 3 clinical trials of a novel oral anticoagulant in patients with non-valvular atrial fibrillation or symptomatic venous thromboembolism TOKYO and PARSIPPANY, N.J., Jan. 8, 2014 /PRNewswire/ -- Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the New Drug Application (NDA) for its investigational, oral, once-daily direct factor Xa-inhibitor SAVAYSA(TM) (edoxaban) Tablets has been submitted to the U.S. Food...

2014-01-07 23:00:15

The DrugRisk Center is the largest source on the Web for information on prescription drug research, side effects and legal news. Visit http://www.DrugRisk.com Chicago, IL (PRWEB) January 07, 2014 For 2014, the prescription drug safety advocates at DrugRisk.com have launched a new patient resource center for women who have taken the birth control pills Yaz or Yasmin. The site will offer the latest research, warnings and legal news on contraceptives like Yaz that use the hormone...

2014-01-07 12:28:27

Submission based on the two largest comparative phase 3 clinical trials of a novel oral anticoagulant in patients with non-valvular atrial fibrillation or symptomatic venous thromboembolism TOKYO and MUNICH, Jan. 7, 2014 /PRNewswire/ -- Daiichi Sankyo, Company Limited (hereafter, Daiichi Sankyo) today announced that the Marketing Authorization Application (MAA) for its investigational, oral, once-daily direct factor Xa-inhibitor edoxaban has been submitted to the European Medicines Agency...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.